Navidea Biopharmaceuticals, Inc. (NAVBQ)
Develops imaging agents that help doctors detect inflammation and target immune cells for diagnostic and treatment purposes.
$0.00+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-80.0%
The outlook
NAVBQ is trading at its 52-week low with minimal analyst coverage available. The stock sits well below both its 50- and 200-day moving averages, reflecting a sustained downtrend. Current market positioning shows weak technical footing with a bearish overall lean.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$10,008
52-wk high
$0.04
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—